✦ LIBER ✦

Nephrogenic systemic fibrosis: What the hospitalist needs to know

✍ Scribed by Derek M. Fine; Mark A. Perazella

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 127 KB
Volume: 5
Category: Article
ISSN: 1553-5592
DOI: 10.1002/jhm.493

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Nephrogenic systemic fibrosis (NSF) has now been linked to gadolinium‐based contrast (GBC) exposure in those with compromised kidney function, particularly those with end‐stage renal disease (ESRD). When ESRD is present, symptoms can be quite devastating for the patient including severe pain and immobility and even death. For those at risk, avoidance of GBC exposure, whenever possible, is absolutely essential to prevent this potentially devastating complication. Identifying those at risk depends in some circumstances on appropriate recognition of renal dysfunction and understanding appropriate use of glomerular filtration rate (GFR) estimation formulas. Although hemodialysis (but not peritoneal dialysis) removes gadolinium, the availability of dialysis should never be used as a justification for GBC use in this high‐risk population. Unfortunately there is a lack of a universally effective therapy. Resolution of acute kidney injury (AKI) appears to attenuate disease in most cases, while kidney transplantation has been associated with variable success. Journal of Hospital Medicine 2010;5:46–50. © 2010 Society of Hospital Medicine.

📜 SIMILAR VOLUMES

Nephrogenic systemic fibrosis: The need

Nephrogenic systemic fibrosis: The need for accurate case reporting

✍ Alberto Spinazzi; Miles A. Kirchin; Gianpaolo Pirovano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

We have read with great interest the recent editorial by Dr. Peter Dawson entitled "Nephrogenic Systemic Fibrosis: Possible Mechanisms and Imaging Management Strategies" which appeared in the October issue of the Journal of Magnetic Resonance Imaging (1). Although the article is well written, there

Biofouling control in industrial water s

Biofouling control in industrial water systems: What we know and what we need to know

✍ T. E. Cloete 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 German ⚖ 84 KB 👁 1 views

## Abstract Biofouling contributes substantially to economic losses in industry. Although much progress has been made in understanding biofouling and its implications in industrial water systems, many questions remain unanswered. The cost of biofouling has not been enumerated. A prerequisite for t

Internationalizing the campus: What do y

Internationalizing the campus: What do you need to know?

✍ Beth H. Carmical 📂 Article 📅 2002 🏛 John Wiley and Sons ⚖ 45 KB 👁 2 views

## Abstract For those who are in the beginning stages of creating study abroad programs, a road map for navigating the process of developing those programs can be a useful tool.

What the new risk manager needs to know

What the new risk manager needs to know about insurance

✍ Montague, Alan S. 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) ⚖ 456 KB

Tuberculosis in the cytokine era: What r

Tuberculosis in the cytokine era: What rheumatologists need to know

✍ Carol Dukes Hamilton 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Anticytokine agents and other biologic response modifiers represent an important advance in the treatment of rheumatoid arthritis (RA) and other inflammatory diseases. While these agents are specific in their targets, they are not precise enough in their actions to avoid the negative consequences of

Next generation: What leaders need to kn

Next generation: What leaders need to know about the millennials

✍ Kris Downing 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 503 KB

## Abstract It's a unique time in the workplace as four generations of workers are intermingling. As the most recent generation enters the workforce, the challenge for leaders is not only to understand the differences between the generations but also to embrace their different perspectives and find